Issue 74, 2015

Doxorubicin loaded chitosan–ZnO hybrid nanospheres combining cell imaging and cancer therapy

Abstract

We report chitosan–ZnO nanoparticles (CZNPs), which have enhanced photoluminescence stability and longer retention time in cells compared with pure ZnO QDs. These CZNPs can illuminate the cells, show the distribution of the nanospheres in the cell, and thus monitor the fate of the loaded drug, which enable these CZNPs to have a promising future in cell imaging and cancer therapy.

Graphical abstract: Doxorubicin loaded chitosan–ZnO hybrid nanospheres combining cell imaging and cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
21 May 2015
Accepted
08 Jul 2015
First published
08 Jul 2015

RSC Adv., 2015,5, 60549-60551

Author version available

Doxorubicin loaded chitosan–ZnO hybrid nanospheres combining cell imaging and cancer therapy

H. Zhao, P. Lv, D. Huo, C. Zhang, Y. Ding, P. Xu and Y. Hu, RSC Adv., 2015, 5, 60549 DOI: 10.1039/C5RA09587E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements